Literature DB >> 31524886

A scoping review of Lyme disease research relevant to public health.

J D Greig1, I Young2, S Harding1, M Mascarenhas1, L A Waddell1.   

Abstract

Lyme disease (LD) is an emerging infectious disease in Canada associated with expansion of the geographic range of the tick vector Ixodes scapularis in eastern and central Canada. A scoping review of published research was prioritized to identify and characterize the scientific evidence concerning key aspects of LD to support public health efforts. Prior to initiation of this review, an expert advisory group was surveyed to solicit insight on priority topics and scope. A pre-tested search strategy implemented in eight databases (updated September 2016) captured relevant research. Pre-tested screening and data characterization forms were completed by two independent reviewers and descriptive analysis was conducted to identify topic areas with solid evidence and knowledge gaps. Of 19,353 records screened, 2,258 relevant articles were included in the review under the following six public health focus areas: a) surveillance/monitoring in North America (n=809); b) evaluation of diagnostic tests (n=736); c) risk factors (n=545); d) public health interventions (n=205); e) public knowledge, attitudes and/or perceptions in North America (n=202); and f) the economic burden of LD or cost-benefit of interventions (n=32). The majority of research investigated Borrelia burgdorferi (n=1,664), humans (n=1,154) and Ixodes scapularis (n=459). Sufficient research was identified for potential systematic reviews in four topic areas: a) accuracy of diagnostic tests; b) risk factors for human illness; c) efficacy of LD intervention strategies; and d) prevalence and/or incidence of LD in humans or B. burgdorferi sensu stricto in vertebrate reservoirs or ticks in North America. Future primary research could focus on closing knowledge gaps, such as the role of less studied vertebrate reservoirs in the transmission cycle. Results of this scoping review can be used to quickly identify and summarize relevant research pertaining to specific questions about LD or B. burgdorferi sensu lato in humans, vertebrate hosts or vectors, providing evidence-informed information within timelines that are conducive for public health decision-making.

Entities:  

Keywords:  Ixodes ticks; Lyme disease; Scoping review; public health; research

Year:  2018        PMID: 31524886      PMCID: PMC6707479          DOI: 10.14745/ccdr.v44i10a03

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  55 in total

1.  Poor sales trigger vaccine withdrawal.

Authors:  Emma Hitt
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

2.  A controlled trial of a novel primary prevention program for Lyme disease and other tick-borne illnesses.

Authors:  Lawren H Daltroy; Charlotte Phillips; Robert Lew; Elizabeth Wright; Nancy A Shadick; Matthew H Liang
Journal:  Health Educ Behav       Date:  2007-04-27

3.  The art and science of knowledge synthesis.

Authors:  Andrea C Tricco; Jennifer Tetzlaff; David Moher
Journal:  J Clin Epidemiol       Date:  2010-03-01       Impact factor: 6.437

4.  Peridomestic Lyme disease prevention: results of a population-based case-control study.

Authors:  Neeta P Connally; Amanda J Durante; Kimberly M Yousey-Hindes; James I Meek; Randall S Nelson; Robert Heimer
Journal:  Am J Prev Med       Date:  2009-09       Impact factor: 5.043

Review 5.  Scoping Review of Research on the Effectiveness of Food-Safety Education Interventions Directed at Consumers.

Authors:  Bhairavi Sivaramalingam; Ian Young; Mai T Pham; Lisa Waddell; Judy Greig; Mariola Mascarenhas; Andrew Papadopoulos
Journal:  Foodborne Pathog Dis       Date:  2015-06-02       Impact factor: 3.171

Review 6.  Human Lyme disease vaccines: past and future concerns.

Authors:  Dean T Nardelli; Erik L Munson; Steven M Callister; Ronald F Schell
Journal:  Future Microbiol       Date:  2009-05       Impact factor: 3.165

Review 7.  The Health Belief Model: a decade later.

Authors:  N K Janz; M H Becker
Journal:  Health Educ Q       Date:  1984

Review 8.  A scoping review of scoping reviews: advancing the approach and enhancing the consistency.

Authors:  Mai T Pham; Andrijana Rajić; Judy D Greig; Jan M Sargeant; Andrew Papadopoulos; Scott A McEwen
Journal:  Res Synth Methods       Date:  2014-07-24       Impact factor: 5.273

9.  Study on public perceptions and protective behaviors regarding Lyme disease among the general public in the Netherlands: implications for prevention programs.

Authors:  Desirée Jacqueline Mathieu Angélique Beaujean; Marloes Bults; Jim Everardus van Steenbergen; Hélene Antoine Claire Marie Voeten
Journal:  BMC Public Health       Date:  2013-03-15       Impact factor: 3.295

10.  Estimated effects of projected climate change on the basic reproductive number of the Lyme disease vector Ixodes scapularis.

Authors:  Nicholas H Ogden; Milka Radojevic; Xiaotian Wu; Venkata R Duvvuri; Patrick A Leighton; Jianhong Wu
Journal:  Environ Health Perspect       Date:  2014-03-14       Impact factor: 9.031

View more
  4 in total

1.  A scoping review of Lyme disease research relevant to public health.

Authors:  J D Greig; I Young; S Harding; M Mascarenhas; L A Waddell
Journal:  Can Commun Dis Rep       Date:  2018-10-04

2.  Parenting When Children Have Lyme Disease: Fear, Frustration, Advocacy.

Authors:  Emilie M Gaudet; Odette N Gould; Vett Lloyd
Journal:  Healthcare (Basel)       Date:  2019-08-08

3.  Epizootiological aspects of natural nidality of Ixodes tick-borne borreliosis in the Moscow region (Russian Federation).

Authors:  Almas Mukhametov; Mikhail Osadchuk; Iza Berechikidze; Nikolay Pronkin
Journal:  Vet World       Date:  2022-01-30

4.  Lyme neuroborreliosis in Swedish children-PCR as a complementary diagnostic method for detection of Borrelia burgdorferi sensu lato in cerebrospinal fluid.

Authors:  Barbro H Skogman; Peter Wilhelmsson; Stephanie Atallah; Ann-Cathrine Petersson; Katarina Ornstein; Per-Eric Lindgren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-02       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.